Evidence for a putatively new angiotensin II-Generating enzyme in the vascular wall

Journal of Hypertension

Volumn 2, Issue 3, 1984, Pages 277-284

  Okunishi, Hideki ^a   Miyazaki, Mizuo ^a   Toda, Noboru ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Angiotensin I converting enzyme inhibitor; Angiotensin ll generating enzyme; Chymostatin; High performance liquid chromatography; Isolated vessel

Indexed keywords

ANGIOTENSIN; CHYMOSTATIN; DIPEPTIDYL CARBOXYPEPTIDASE;

BLOOD VESSEL WALL; CARDIOVASCULAR SYSTEM; CYTOLOGY; DOG; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PERIPHERAL VASCULAR SYSTEM;

3-MERCAPTOPROPIONIC ACID; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINS; ANIMAL; BLOOD VESSELS; COMPARATIVE STUDY; DOGS; FEMALE; IN VITRO; MACACA; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; OLIGOPEPTIDES; SULFHYDRYL COMPOUNDS; SUPPORT, NON-U.S. GOV'T;

EID: 0021265674     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-198406000-00010     Document Type: Article

References (30)

1. Helmer OM: Differentiation between two forms of angiotensin by means of spirally cut strips of rabbit aorta. Am J Physiol 1957, 188:571-577.
2. Peach MJ, Bumpus FM, Khairallah PA: Release of adrenal catecholamines by angiotensin I. J Pharmacol Exp Ther 1971, 176:366-376.
3. Itskovitz HD, McGiff JC: Hormonal regulation of the renal circulation. Circ Res 1974, 34 and 35 (suppl I):I-65-I-73.
4. Aiken JW, Vane JR: The renin-angiotensin system: inhibition of converting enzyme in isolated tissues. Nature 1970, 228:30-34.
5. Toda N, Hayashi S, Miyazaki M: Contractile responses of isolated dog mesenteric arteries to angiotensin I, II and III. Jpn J Pharmacol 1978, 28:527-534.
6. Boucher R, Saidi M, Genest J: A new 'angiotensin I converting enzyme' system. In Hypertension edited by Genest J, Koiw E, Berlin, Heidelberg, New York: Springer-Verlag, 1972, pp 512-532.
7. Grandino A, Paiva ACM: Isolation of angiotensin-converting enzyme without kininase activity from hog and guinea pig plasma. Biochim Biophys Acta 1974, 364:113-119.
8. Overturf M, Wyatt S, Boaz D, Fitz A: Angiotensin I [Phe8-His9] hydrolase and bradykininase from human lung. Life Sci 1976, 16:1669-1682.
9. Wintroub BU, Klickstein LB, Watt KWK: A human neutrophil-dependent pathway for generation of angiotensin II. Purification of the product and identification as angiotensin II. J Clin Invest 1981,68:484-490.
10. Iso T, Yamauchi H, Suda H, Nakata K, Nishimura K, Iwao J: A new potent inhibitor of converting enzyme: (2R,4R)-2-hydroxy-phenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid (SA446). Jpn J Pharmacol 1981, 31:875-882.
11. Miyazaki M, Okunishi H, Nishimura K, Toda N: Vascular angiotensin-converting enzyme activity in man and other species, Clin Sci 1984, 66:39-45
12. Toda N: Mechanism of vascular smooth muscle relaxation induced by angiotensins. In Vasodilatation edited by Vanhoutte PM, Leusen I, New York: Raven Press, 1981, pp 151-157.
13. Guy MN, Robertson GM, Barnes LD: Analysis of angiotensin I, II, III and iodinated derivatives by high-performance liquid chromatography. Anal Biochem 1981,112:272-277.
14. Horiuchi M, Fujimura K, Terashima T, Iso T: Method for determination of angiotensin-converting enzyme activity in blood and tissue by high-performance liquid chromatography. J Chromatogr 1982, 233:123-130.
15. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
16. Cushman DW, Cheung HS, Sabo EF, Rubin B, Ondetti MA: Development of specific inhibitors of angiotensin I converting enzyme (kininase II). Fed Proc 1979, 38:2778-2782.
17. Di Salvo J, Peterson A, Montefusco CB, Menta M: Intrarenal conversion of angiotensin I to angiotensin II in the dog. Circ Res 1971,29:398-406.
18. Di Salvo J, Montefusco CB: Conversion of angiotensin I to angiotensin II in the canine mesenteric circulation. Am J Physiol 1971,221:1576-1579.
19. Di Salvo J, Britton S, Galvas P, Sanders TW: Effects of angiotensin I and angiotensin II on canine hepatic vascular resistance. Circ Res 1973, 32:85-92.
20. Cushman DW, Cheung HS: Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 1971, 20:1637-1648.
21. Feinstein G, Malemud CJ, Janoff A: The inhibition of human leucocyte elastase and chymotrypsin-like protease by elastatinal and chymostatin. Biochim Biophys Acta 1976, 429:925-932.
22. Johnson EM Jr, Marshall GR, Needleman P: Modification of responses to sympathetic nerve stimulation by the renin-angiotensin system in rats. Br J Pharmacol 1974, 51:541-547.
23. Swanson LW, Marshall GR, Needleman P, Sharpe LG: Characterization of central angiotensin II receptors involved in the elicitation of drinking in the rat. Brain Res 1973, 49:441-446.
24. Thibault G, Genest J: Tonin, an esteroprotease from rat submaxillary glands. Biochim Biophys Acta 1981, 660:23-29.
25. Tremblay J, Thibault G, Gutkowska J, Boucher R, Genest J: Purification and partial characterization of a plasma inhibitor of tonin. Can J Biochim 1981, 59:256-261.
26. Oparil S, Koerner T, O’Bonoghue JK: Mechanism of angiotensin I converting enzyme inhibition by SQ20881 (Glu-Try-Pro-Arg-Pro-Gln-lle-Pro-Pro) in vivo. Further evidence for extrapulmonary conversion. Hypertension 1979,1:13-22.
27. Tonnesen MG, Klempner MS, Austen KF, Wintroub BU: Identification of a human neutrophil angiotensin ll-generating protease as cathepsin G. J Clin Invest 1982, 69:25-30.
28. Starkey PM: Elastase and cathepsin G; the serine proteinases of human neutrophil leucocytes and spleen. In Proteinases in Mammalian Cells and Tissues edited by Barrett AJ, Amsterdam: Elsevier/North Holland Biochemical Press, 1977 pp 57-89.
29. Starkey PM, Barrett AJ: Human cathepsin G. Catalytic and immunological properties. Biochem J 1976,155:273-278.
30. Klickstein LB, Kaempfer CE, Wintroub BU: The granulocyte-angiotensin system. Angiotensin l-converting activity of cathepsin G. J Biol Chem 1982, 257:15042-15046